Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer

(2017) Jacopo Desiderio et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine

(2016) Tsafrir Vanounou et al.   ANNALS OF SURGICAL ONCOLOGY

Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients

(2015) Florian Seyfried et al.   BMC CANCER

Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis

(2015) Y.R. Huo et al.   EJSO

Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich

(2015) Uwe Bieri et al.   VIRCHOWS ARCHIV

Quality of Life in Peritoneal Carcinomatosis: A Prospective Study in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

(2014) Markus Albertsmeier et al.   DIGESTIVE SURGERY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery

(2014) Hakeam A. Hakeam et al.   RENAL FAILURE

Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience

(2014) Marie-Elisabeth Kajdi et al.   World Journal of Surgical Oncology

Comparison Different Methods of Intraoperative and Intraperitoneal Chemotherapy for Patients with Gastric Cancer: A Meta-analysis

(2013) Jin-Yu Huang et al.   Asian Pacific Journal of Cancer Prevention

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience

(2013) L. H. Iversen et al.   Colorectal Disease

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

(2013) F. Coccolini et al.   EJSO

Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials

(2013) Deng-Hai Mi et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma

(2013) Kaitlyn J. Kelly et al.   JOURNAL OF SURGICAL ONCOLOGY

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials

(2012) Jingxu Sun et al.   BMC CANCER

Chemotherapy in the Treatment of Metastatic Gastric Cancer: Is There a Global Standard?

(2011) Hyunseok Kang et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity

(2011) Richdeep S. Gill et al.   JOURNAL OF SURGICAL ONCOLOGY

Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)

(2011) Timothy J Cooksley et al.   World Journal of Surgical Oncology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY